|
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Τρίτη 11 Σεπτεμβρίου 2018
Scholar : Journal of Tourism and Cultural Change, Volume 16, Issue 4, September 2018 is now available online on Taylor & Francis Online
Incision Choices in Nipple-Sparing Mastectomy: A Comparative Analysis of Outcomes and Evolution of a Clinical Algorithm
https://ift.tt/2N7H1os
Unplanned Emergency Department Visits within 30-Days of Mastectomy and Breast Reconstruction
https://ift.tt/2Oa5zda
The Relationship between Bone Remodeling and the Clockwise Rotation of the Facial Skelton – A Computed Tomography Imaging based Evaluation
https://ift.tt/2N2cM2p
The Stacked Hemi-Abdominal Extended Perforator (SHAEP) flap for autologous breast reconstruction
https://ift.tt/2Oa5x52
“The Constriction Arm Band Deformity in Brachioplasty Patients: Characterization and Incidence Using a Prospective Registry”
https://ift.tt/2N4Xj1J
Development of the BODY-Q Chest Module Evaluating Outcomes Following Chest Contouring Surgery
https://ift.tt/2Oa5ruc
“Fat Grafting for Pedal Fat Pad Atrophy in a 2-Year, Prospective, Randomized Cross-over, Single-Center Clinical Trial”
https://ift.tt/2N90SUz
Immediate Implant-Based Breast Reconstruction with Acellular Dermal Matrix: A Comparison of Sterile and Aseptic AlloDerm in 2039 Consecutive Cases
https://ift.tt/2OcDnGn
Dominant men are faster in decision-making situations and exhibit a distinct neural signal for promptness
https://ift.tt/2CJn6rc
Nimotuzumab for Recurrent Nasopharyngeal Carcinoma
Intervention: Drug: Nimotuzumab
Sponsors: Fujian Cancer Hospital; Sun Yat-sen University; Jiangxi Provincial Cancer Hospital; Zhejiang Cancer Hospital; Fujian Medical University Union Hospital
Recruiting
https://ift.tt/2x3xN1J
A First-in-human Study of ILDR2 (Immunoglobulin-like Domain Containing Receptor 2) Function-blocking Antibody BAY1905254
Intervention: Drug: BAY1905254
Sponsor: Bayer
Not yet recruiting
https://ift.tt/2x1G9rJ
Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance
Interventions: Drug: Pembrolizumab; Drug: Cetuximab
Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; Merck Sharp & Dohme Corp.
Not yet recruiting
https://ift.tt/2x91KxI
Pathophysiological Mechanism Behind Prolonged Whiplash Associated Disorders
Intervention: Other: Exercises
Sponsor: Linkoeping University
Not yet recruiting
https://ift.tt/2x0J6sA
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
Intervention: Drug: NC318
Sponsor: NextCure, Inc.
Not yet recruiting
https://ift.tt/2x91xKW
Scholar : Research in Drama Education: The Journal of Applied Theatre and Performance, Volume 23, Issue 4, November 2018 is now available online on Taylor & Francis Online
|
Uptake effects of toxic heavy metals from growth soils into jujube and persimmon of China
Abstract
Compared with other agricultural plants, information about uptake effects of toxic heavy metals from growth soils into persimmon and jujube are scarce. In this study, the single and comprehensive uptake effects of five toxic heavy metals (Pb, As, Cd, Cr, and Hg) between the two fruits and their growth soils were investigated. The results showed that the average concentrations of heavy metals in the two fruits were found to be 30 (Pb), 6.6 (As), 2.3 (Cd), 38 (Cr), and 0.33 (Hg) μg/kg, respectively. The average concentrations of heavy metals in their growth soils were 26.31 (Pb), 9.63 (As), 0.12 (Cd), 57.6 (Cr), and 0.049 (Hg) mg/kg, respectively. An uptake effect was observed for the two fruits. The values of Nemerow pollution index (NPI) in the two fruits and their growth soils were 0.10 and 0.55, respectively. The average bioconcentration factor (BCF) values of Pb, As, Cd, Cr, and Hg in the two fruits were 0.0012, 0.00075, 0.021, 0.00077, and 0.012, respectively. Based on the residue levels of toxic heavy metals in the growth soils and soil parameters, the prediction models for NPI and BCF were established, with the adjusted regression coefficients of 0.65 (NPI) and 0.81 (BCF). The contribution rates of different soil parameters to NPI were 21.7% (OC), 16.1% (Pb), 17.1% (Cr), 19.8% (Cd), and 25.4% (As), respectively. The contribution rates of different soil parameters to BCF were 10.2% (OC), 9.4% (Cr), and 80.4% (Cd), respectively.
https://ift.tt/2oVGRlQ
Role of sorption energy and chemisorption in batch methylene blue and Cu 2+ adsorption by novel thuja cone carbon in binary component system: linear and nonlinear modeling
Abstract
Functionalized thuja cone carbon (FTCC) was synthesized thermochemically. It was carried out by carbonization (250 °C) and activation (320 °C), followed by surface functionalization in 0.5 M HAN (HNO and HCl3) mixture and subsequent heating in H2SO4 (95%) at 90 °C. This was used for methylene blue (MB) adsorption in single component system (SCS) and binary component system (BCS) with Cu2+. Maximum adsorption capacity of MB (83.4 mg/g) was achieved at pH 10 at 100 mg/L of adsorbate solution. MB and Cu2+ adsorption onto FTCC obeyed pseudo-second-order model kinetics. Spontaneous and endothermic MB adsorption was noticed with negative Gibbs free energy change (− 6.34, − 9.20, and − 13.78 kJ/mol) and positive enthalpy change (133.91 kJ/mol). At low concentrations, Cu2+ adsorption increased by 14 mg/g with least reduction of MB adsorption (< 4 mg/g) in BCS. Isotherm models (Langmuir, Freundlich, Temkin, and Dubinin-Radushkevich) support the increase in Cu2+ adsorption in BCS. The sorption heat of MB shifted from 165.16 kJ/mol (SCS) to 150.85 kJ/mol in BCS (Temkin) and from 57.74 kJ/mol (SCS) to 50.50 kJ/mol in BCS (D-R), which supports the lower MB uptake in BCS due to decrease in sorption energy. The sorption heat of Cu2+ is increased (148.43 kJ/mol) in the BCS than SCS (155.36 kJ/mol), which makes the equal distribution of increased bonding energies; therefore, FTCC surface sites increased the Cu2+ uptake in the BCS. Desorption studies concluded the reusability of FTCC by 75% and 79% for MB and Cu2+ adsorption respectively. This study recommends to determine the best fit of isotherm and kinetic models to adsorption data by linear as well as nonlinear regression fit.
https://ift.tt/2O9g0xF
Volumetric and texture analysis of pretherapeutic 18 F-FDG PET can predict overall survival in medullary thyroid cancer patients treated with Vandetanib
Abstract
Purpose
The metabolically most active lesion in 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) PET/CT can predict progression-free survival (PFS) in patients with medullary thyroid carcinoma (MTC) starting treatment with the tyrosine kinase inhibitor (TKI) vandetanib. However, this metric failed in overall survival (OS) prediction. In the present proof of concept study, we aimed to explore the prognostic value of intratumoral textural features (TF) as well as volumetric parameters (total lesion glycolysis, TLG) derived by pre-therapeutic 18F-FDG PET.
Methods
Eighteen patients with progressive MTC underwent baseline 18F-FDG PET/CT prior to and 3 months after vandetanib initiation. By manual segmentation of the tumor burden at baseline and follow-up PET, intratumoral TF and TLG were computed. The ability of TLG, imaging-based TF, and clinical parameters (including age, tumor marker doubling times, prior therapies and RET (rearranged during transfection) mutational status) for prediction of both PFS and OS were evaluated.
Results
The TF Complexity and the volumetric parameter TLG obtained at baseline prior to TKI initiation successfully differentiated between low- and high-risk patients. Complexity allocated 10/18 patients to the high-risk group with an OS of 3.3 y (vs. low-risk group, OS = 5.3 y, 8/18, AUC = 0.78, P = 0.03). Baseline TLG designated 11/18 patients to the high-risk group (OS = 3.5 y vs. low-risk group, OS = 5 y, 7/18, AUC = 0.83, P = 0.005). The Hazard Ratio for cancer-related death was 6.1 for Complexity (TLG, 9.5). Among investigated clinical parameters, the age at initiation of TKI treatment reached significance for PFS prediction (P = 0.02, OS, n.s.).
Conclusions
The TF Complexity and the volumetric parameter TLG are both independent parameters for OS prediction.
https://ift.tt/2Qg5nup
Impulse control disorders in patients with prolactinoma receiving dopamine agonist therapy: a prospective study with 1 year follow-up
Abstract
Objective
To assess prospectively the prevalence of impulse control disorders (ICD), psychiatric symptoms, and their clinical correlates in patients with prolactinoma receiving dopamine agonists (DA) in comparison to those with non-functioning pituitary adenomas (NFA) and healthy controls (HC).
Methods
A total of 25 patients with prolactinoma, 31 with NFA, and 32 HCs were included in the study. All patients and controls were screened for the presence of ICDs and other psychiatric disorders using revised version of Minnesota Impulsive Disorders Interview (MIDI-R), Barratt Impulsiveness Scale (BIS-11), Symptom Check List (SCL-90-R) questionnaire and Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI).
Results
We detected two new cases (8%) of ICD associated with DAs. Both cases presented with hypersexuality, which reversed totally or decreased upon discontinuation of the drug. The re-challenge of the DA in a smaller dose has led to either no symptoms or weaker symptoms than before. There was an increase in the number of patients who screened positive on obsession, interpersonal sensitivity, paranoid ideation, and additional items subscales of SCL-90-R in comparison to HCs at the end of the study period (p < 0.05 for all). Likewise, cumulative DA dose was positively correlated to obsession, interpersonal sensitivity, paranoid ideation, hostility, phobic anxiety subscales, and GSI scores of SCL-90-R (p < 0.05 for all).
Conclusions
DAs are associated with a small but substantial short-term risk of ICD development and a broad range of psychiatric symptoms in patients with prolactinoma receiving DAs.
https://ift.tt/2MkAfGE
-
Ειδοποίηση Μελετητή:[ ωτα ] [HTML] Gender, identity and material: Film screening C Brand - 2017 ftypM4V *M4V M4A mp42isom*a┌moovlmvhd...
-
Publication date: September 2017 Source: Free Radical Biology and Medicine, Volume 110 Author(s): Lucía Fernández-del-Río, Anish Nag, Elen...
